News Sanara MedTech Inc.

Equities

SMTI

US79957L1008

Delayed Nasdaq Other stock markets 03:45:50 2024-05-15 pm EDT			5-day change	1st Jan Change
33.73 ^USD	+12.97%		+2.66%	-17.92%

May. 14	Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024
May. 13	Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024	May. 14
Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down	May. 13	MT
Sanara MedTech CEO Zachary Fleming Resigns	May. 13	MT
Sanara MedTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Sanara MedTech Inc. Announces First Quarter 2024 Results	May. 13	AQ
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates	Apr. 29	AQ
Sanara MedTech Inc. Announces $55 Million Debt Facility	Apr. 18	AQ
Sanara Medtech Inc. Announces $55 Million Debt Facility	Apr. 18	CI
Sanara MedTech Appoints Jake Waldrop as Chief Operating Officer	Apr. 05	MT
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer	Apr. 05	AQ
Sanara MedTech Inc. Announces Executive Changes, Effective April 15, 2024	Apr. 05	CI
Cantor Fitzgerald Cuts Price Target on Sanara MedTech to $44 From $49, Maintains Overweight Rating	Mar. 27	MT
Transcript : Sanara MedTech Inc., Q4 2023 Earnings Call, Mar 26, 2024	Mar. 26
Earnings Flash (SMTI) SANARA MEDTECH Posts Q4 Revenue $17.7M, vs. Street Est of $16.5M	Mar. 25	MT
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results	Mar. 25	AQ
Sanara MedTech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates	Mar. 13	AQ
Sanara MedTech Reports Higher Preliminary Q4 Revenue	Feb. 22	MT
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023	Feb. 22	AQ
Sanara MedTech Inc. Announces Unaudited Preliminary Net Revenue Results for the Fourth Quarter and Full-Year 2023	Feb. 22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Sanara MedTech Inc.

Equities

SMTI

US79957L1008

Summary

Filters